According to a new report, published by KBV research, The Global Endoscope Reprocessing Market size is expected to reach $2.8 billion by 2031, rising at a market growth of 9.0% CAGR during the forecast period.
The Outpatient Facilities market dominated the Global Endoscope Reprocessing Market by End-use in 2023; thereby, achieving a market value of $1.4 billion by 2031. There has been a notable increase in the number of medical procedures performed in outpatient settings. Factors such as cost-effectiveness, convenience, and advances in minimally invasive surgery have contributed to this trend. As the volume of outpatient procedures rises, so does the demand for endoscope reprocessing services and equipment in these facilities.
The Automated Endoscope Reprocessors (AERs) market is expected to witness a CAGR of 8.7% during (2024 - 2031). AERs are devices used in healthcare facilities to automate and standardise endoscopes' reprocessing (cleaning, disinfection, and sterilisation). Compared to manual methods, these machines are designed to improve endoscope reprocessing efficiency, consistency, and safety. AERs can ensure that each endoscope undergoes the same reprocessing steps, reducing the risk of errors and ensuring a high level of disinfection.
Full Report: https://www.kbvresearch.com/endoscope-reprocessing-market/
The North America region dominated the Global Endoscope Reprocessing Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1 billion by 2031. The Europe region is exhibiting a CAGR of 8.6% during (2024 - 2031). Additionally, The Asia Pacific region would experience a CAGR of 9.8% during (2024 - 2031).
By End-use
By Product
Unique Offerings 
